US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 7.000
  • +0.220+3.24%
Close Dec 24 13:00 ET
  • 6.900
  • -0.100-1.43%
Post 17:01 ET
330.50MMarket Cap-4.15P/E (TTM)

Silence Therapeutics Key Stats

Silence Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
--2024/Q112.406M / 3.550M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 3.733M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
--2024/Q112.406M / 3.550M--

Unlock Free Earnings Estimates

Silence Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 2, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data